MedPlus Health Services (MEDPLUS.NS) Stock Price

MedPlus Health Services Price

NSE·CLOSED
623.90
​
Market closed

Over the last 7 years MedPlus Health Services grew revenue by 17.1% annually, reaching 67.29 B INR. Earnings per share have grown at 51.6% per year over the last 7 years. For MedPlus Health Services, the net margin of 3.3% is broadly stable versus 2.6% a few years ago. The consensus 12-month price target for MedPlus Health Services is 1,106.70 INR, about 77.4% above where the stock trades today. Of 12 analysts, 11 rate the stock a buy — an overall Buy consensus.

MedPlus Health Services stock price

Access this data via the Eulerpool API

MedPlus Health Services business model & stock analysis

MedPlus Health Services Ltd. engages in the operation of pharmacies. The company is headquartered in Hyderabad, Telangana and currently employs 21,000 full-time employees. The company went IPO on 2021-12-23. The firm is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. The company operates through two segments: Retail and Diagnostics. The Retail segment is engaged in retail trading of medicines and general items. The Diagnostics segment is engaged in the diagnostic services. The firm operates approximately 3,882 stores in 552 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its subsidiaries include Optival Health Solutions Private Limited, MHS Pharmaceuticals Private Limited, Kalyani Meditimes Private Limited, and others.

Frequently asked questions about MedPlus Health Services

Analysts currently set an average price target of 1,114.35 INR for the MedPlus Health Services stock (median: 1,106.70 INR), implying +78.6 % versus the latest price. The consensus is based on 12 analyst ratings.

12 analysts currently rate the MedPlus Health Services stock: 11 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the MedPlus Health Services share trades at 5.76 EUR (623.90 INR).

The MedPlus Health Services share (MEDPLUS.NS) is listed on 2 stock exchanges, including: NSE (Indien) (MEDPLUS.NS).

The revenue of MedPlus Health Services is 67.29 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of MedPlus Health Services is 2.20 B INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of MedPlus Health Services is currently 34.11. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the MedPlus Health Services stock.

The price-to-sales ratio (P/S) of MedPlus Health Services is currently 1.11. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the MedPlus Health Services stock.

The Eulerpool Quality Score for MedPlus Health Services is 4/10.

The ISIN of MedPlus Health Services is INE804L01022. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of MedPlus Health Services is MEDPLUS.NS. The ticker symbol is used to trade MedPlus Health Services shares on the stock exchange.

Fair ValueTerminal
561.51 INR
Over-/UndervaluationTerminal
Fairly valued
Industry
Consumer Staples Distribution & Retail
Number of shares
Employees
Revenue per Employee
3.20 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Dec 23, 2021
ISIN
INE804L01022
Cusip
Y594L1109
Market capitalization
74.87 B INRLarge Cap
52-Week Range
PEG
1.24
P/E ratio
P/Ee 2027
36.10
P/Ee 2028
23.13
P/Ee 2029
17.39
P/Ee 2030
—
P/Ee 2031
—
P/S
P/Se
0.93
EV/EBIT
26.04
P/B Ratio
3.79
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
6.46 %
Last updated Oct 10, 2026, 9:48 AM

MedPlus Health Services Peer Group

MedPlus Health Services Ticker

BSE · MEDPLUS.BONSE INDIA · MEDPLUS.NS

MedPlus Health Services FIGI

MEDPLUS:IN · BBG0021TWN59MEDPLUS:IB · BBG013YXGVH8MEDPLUS:IS · BBG013YXGVK4